UCP2 and obesity due to melanocortin 4 receptor deficiency: Based on studies, modifying the expression of genes that regulate UCP-2 expression and functions is a promising therapeutic approach for controlling insulin resistance, obesity, and body-weight gain or body mass index (BMI) [19].